In-vivo measurement of osteoporotic bone fragility with apparent velocity of ultrasound

G. Brandenburger, L. Avioli, C. Chesnut, R. Heaney, S. McDougall, C. Olson, Robert R. Recker, C. Turner

Research output: Chapter in Book/Report/Conference proceedingConference contribution

3 Citations (Scopus)

Abstract

The authors first present a brief review of the motivation for ultrasound assessment of bone fragility, and then they discuss the principal sources of artifacts in measurements of apparent velocity (AVU) in vivo. They then describe the SIGNATURE WAVEFORM, a novel approach to reducing the largest source artifact in the measurement of AVU in bone: inhomogeneity. Theory, specific details of implementation, and results of clinical tests are given for this approach. It is noted that the SIGNATURE WAVEFORM approach now provides long-term reproducibility. Coupled with the proven ability to detect osteoporotic bone fragility, AVU appears ready for routine clinical application.

Original languageEnglish
Title of host publicationBiomedical Engineering Perspectives: Health Care Technologies for the 1990's and Beyond
PublisherPubl by IEEE
Pages338-339
Number of pages2
Editionpt 1
ISBN (Print)0879425598
StatePublished - 1990
EventProceedings of the 12th Annual International Conference of the IEEE Engineering in Medicine and Biology Society - Philadelphia, PA, USA
Duration: Nov 1 1990Nov 4 1990

Other

OtherProceedings of the 12th Annual International Conference of the IEEE Engineering in Medicine and Biology Society
CityPhiladelphia, PA, USA
Period11/1/9011/4/90

Fingerprint

Bone
Ultrasonics

All Science Journal Classification (ASJC) codes

  • Bioengineering

Cite this

Brandenburger, G., Avioli, L., Chesnut, C., Heaney, R., McDougall, S., Olson, C., ... Turner, C. (1990). In-vivo measurement of osteoporotic bone fragility with apparent velocity of ultrasound. In Biomedical Engineering Perspectives: Health Care Technologies for the 1990's and Beyond (pt 1 ed., pp. 338-339). Publ by IEEE.

In-vivo measurement of osteoporotic bone fragility with apparent velocity of ultrasound. / Brandenburger, G.; Avioli, L.; Chesnut, C.; Heaney, R.; McDougall, S.; Olson, C.; Recker, Robert R.; Turner, C.

Biomedical Engineering Perspectives: Health Care Technologies for the 1990's and Beyond. pt 1. ed. Publ by IEEE, 1990. p. 338-339.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Brandenburger, G, Avioli, L, Chesnut, C, Heaney, R, McDougall, S, Olson, C, Recker, RR & Turner, C 1990, In-vivo measurement of osteoporotic bone fragility with apparent velocity of ultrasound. in Biomedical Engineering Perspectives: Health Care Technologies for the 1990's and Beyond. pt 1 edn, Publ by IEEE, pp. 338-339, Proceedings of the 12th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Philadelphia, PA, USA, 11/1/90.
Brandenburger G, Avioli L, Chesnut C, Heaney R, McDougall S, Olson C et al. In-vivo measurement of osteoporotic bone fragility with apparent velocity of ultrasound. In Biomedical Engineering Perspectives: Health Care Technologies for the 1990's and Beyond. pt 1 ed. Publ by IEEE. 1990. p. 338-339
Brandenburger, G. ; Avioli, L. ; Chesnut, C. ; Heaney, R. ; McDougall, S. ; Olson, C. ; Recker, Robert R. ; Turner, C. / In-vivo measurement of osteoporotic bone fragility with apparent velocity of ultrasound. Biomedical Engineering Perspectives: Health Care Technologies for the 1990's and Beyond. pt 1. ed. Publ by IEEE, 1990. pp. 338-339
@inproceedings{b4d84167f2244479a1b0572452fc2085,
title = "In-vivo measurement of osteoporotic bone fragility with apparent velocity of ultrasound",
abstract = "The authors first present a brief review of the motivation for ultrasound assessment of bone fragility, and then they discuss the principal sources of artifacts in measurements of apparent velocity (AVU) in vivo. They then describe the SIGNATURE WAVEFORM, a novel approach to reducing the largest source artifact in the measurement of AVU in bone: inhomogeneity. Theory, specific details of implementation, and results of clinical tests are given for this approach. It is noted that the SIGNATURE WAVEFORM approach now provides long-term reproducibility. Coupled with the proven ability to detect osteoporotic bone fragility, AVU appears ready for routine clinical application.",
author = "G. Brandenburger and L. Avioli and C. Chesnut and R. Heaney and S. McDougall and C. Olson and Recker, {Robert R.} and C. Turner",
year = "1990",
language = "English",
isbn = "0879425598",
pages = "338--339",
booktitle = "Biomedical Engineering Perspectives: Health Care Technologies for the 1990's and Beyond",
publisher = "Publ by IEEE",
edition = "pt 1",

}

TY - GEN

T1 - In-vivo measurement of osteoporotic bone fragility with apparent velocity of ultrasound

AU - Brandenburger, G.

AU - Avioli, L.

AU - Chesnut, C.

AU - Heaney, R.

AU - McDougall, S.

AU - Olson, C.

AU - Recker, Robert R.

AU - Turner, C.

PY - 1990

Y1 - 1990

N2 - The authors first present a brief review of the motivation for ultrasound assessment of bone fragility, and then they discuss the principal sources of artifacts in measurements of apparent velocity (AVU) in vivo. They then describe the SIGNATURE WAVEFORM, a novel approach to reducing the largest source artifact in the measurement of AVU in bone: inhomogeneity. Theory, specific details of implementation, and results of clinical tests are given for this approach. It is noted that the SIGNATURE WAVEFORM approach now provides long-term reproducibility. Coupled with the proven ability to detect osteoporotic bone fragility, AVU appears ready for routine clinical application.

AB - The authors first present a brief review of the motivation for ultrasound assessment of bone fragility, and then they discuss the principal sources of artifacts in measurements of apparent velocity (AVU) in vivo. They then describe the SIGNATURE WAVEFORM, a novel approach to reducing the largest source artifact in the measurement of AVU in bone: inhomogeneity. Theory, specific details of implementation, and results of clinical tests are given for this approach. It is noted that the SIGNATURE WAVEFORM approach now provides long-term reproducibility. Coupled with the proven ability to detect osteoporotic bone fragility, AVU appears ready for routine clinical application.

UR - http://www.scopus.com/inward/record.url?scp=0025561849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025561849&partnerID=8YFLogxK

M3 - Conference contribution

SN - 0879425598

SP - 338

EP - 339

BT - Biomedical Engineering Perspectives: Health Care Technologies for the 1990's and Beyond

PB - Publ by IEEE

ER -